3D Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:1244 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Nov 24BuyHK$84,710Zhaolong GongIndividual43,000HK$1.97
15 Nov 24BuyHK$8,880Zhaolong GongIndividual4,000HK$2.22
07 Nov 24BuyHK$5,925Zhaolong GongIndividual2,500HK$2.37
30 Oct 24BuyHK$24,000Feng ZhouIndividual10,000HK$2.40
21 Oct 24BuyHK$2,540Zhaolong GongIndividual1,000HK$2.54
17 Oct 24BuyHK$6,275Zhaolong GongIndividual2,500HK$2.51
15 Oct 24BuyHK$2,790Zhaolong GongIndividual1,000HK$2.79
09 Oct 24BuyHK$15,200Zhaolong GongIndividual5,000HK$3.04
08 Oct 24BuyHK$42,875Zhaolong GongIndividual12,500HK$3.43
07 Oct 24BuyHK$33,360Zhaolong GongIndividual8,000HK$4.17
04 Oct 24BuyHK$21,200Zhaolong GongIndividual8,000HK$2.65
03 Oct 24BuyHK$19,000Zhaolong GongIndividual5,000HK$3.80
02 Oct 24BuyHK$40,200Zhaolong GongIndividual10,000HK$4.02
30 Sep 24BuyHK$25,350Zhaolong GongIndividual7,500HK$3.38
27 Sep 24BuyHK$8,460Zhaolong GongIndividual3,000HK$2.82
26 Sep 24BuyHK$21,200Zhaolong GongIndividual8,000HK$2.65
25 Sep 24BuyHK$24,100Zhaolong GongIndividual10,000HK$2.41
24 Sep 24BuyHK$15,680Zhaolong GongIndividual7,000HK$2.24
23 Sep 24BuyHK$26,650Zhaolong GongIndividual13,000HK$2.05
19 Sep 24BuyHK$20,000Zhaolong GongIndividual8,000HK$2.50
17 Sep 24BuyHK$12,500Zhaolong GongIndividual5,000HK$2.50
16 Sep 24BuyHK$26,400Zhaolong GongIndividual11,000HK$2.40
13 Sep 24BuyHK$44,000Zhaolong GongIndividual20,000HK$2.20
12 Sep 24BuyHK$14,140Zhaolong GongIndividual7,000HK$2.02
11 Sep 24BuyHK$13,980Zhaolong GongIndividual6,000HK$2.33
10 Sep 24BuyHK$22,240Zhaolong GongIndividual8,000HK$2.78
09 Sep 24BuyHK$5,860Zhaolong GongIndividual2,000HK$2.93
05 Sep 24BuyHK$29,100Zhaolong GongIndividual10,000HK$2.91
04 Sep 24BuyHK$28,900Zhaolong GongIndividual10,000HK$2.89
03 Sep 24BuyHK$29,500Zhaolong GongIndividual10,000HK$2.95

Insider Trading Volume

Insider Buying: 1244 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1244?
Owner TypeNumber of SharesOwnership Percentage
Institutions7,997,0323.26%
Public Companies23,047,4689.41%
Individual Insiders36,311,36414.8%
Private Companies52,055,42121.2%
General Public125,630,55351.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 19 shareholders own 48.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.7%
Kastle Limited
38,338,040HK$111.2m0%no data
14.8%
Zhaolong Gong
36,240,364HK$105.1m0.28%no data
9.41%
Simcere Pharmaceutical Group Limited
23,047,468HK$66.8m0%no data
5.6%
Shenzhen Efung Ruishi Investment Enterprise (Limited Partnership)
13,717,381HK$39.8m0%no data
1.09%
Bosera Asset Management Co., Ltd.
2,675,500HK$7.8m0%no data
0.88%
GF Fund Management Co., Ltd.
2,158,500HK$6.3m0%no data
0.44%
China Asset Management Co. Ltd.
1,087,032HK$3.2m-0.08%no data
0.4%
Huashang Fund Management Company Ltd.
990,000HK$2.9m0%0.01%
0.17%
E Fund Management Co., Ltd.
417,500HK$1.2m0%no data
0.075%
Penghua Fund Management Co., Ltd.
184,000HK$533.6k0%no data
0.049%
Fullgoal Fund Management Co. Ltd.
120,000HK$348.0k0%no data
0.04%
China Southern Asset Management Co., Ltd.
97,500HK$282.8k0%no data
0.04%
Yinhua Fund Management Co., Ltd.
97,000HK$281.3k0%no data
0.026%
Dimensional Fund Advisors LP
63,000HK$182.7k-34.4%no data
0.023%
China Universal Asset Management Company Ltd.
56,000HK$162.4k0%no data
0.02%
Ping An UOB Fund Management Co., Ltd.
50,000HK$145.0k0%no data
0.017%
Pai Zhu
41,000HK$118.9k0%no data
0.012%
Feng Zhou
30,000HK$87.0k50%no data
0.00041%
Hang Seng Investment Management Limited
1,000HK$2.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 13:51
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

3D Medicines Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.